Spero Therapeutics nabs Allergan executive — 3 insights

Spero Therapeutics appointed Ian Critchley, PhD, head of clinical microbiology.

Advertisement

Here’s what you should know.

1. Dr. Critchley will oversee Spero’s preclinical and clinical microbiology efforts.

2. He has more than 30 years of experience in anti-infective drug discovery.

3. Dr. Critchley most recently was Allergan’s vice president of clinical microbiology. At Allergan, he managed preclinical and clinical microbiology studies on anti-infective compounds.

More articles on supply chain:
Copper Ridge Surgery Center awarded for patient care initiative — 5 highlights
Acrometis and PriceMDs bring bundled pricing to workers’ comp space — 5 notes
Humana expands orthopedic bundled payment model to 7 more states

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.